1.
JNMA J Nepal Med Assoc
; 48(174): 162-4, 2009.
Article
in English
| MEDLINE
| ID: mdl-20387361
ABSTRACT
Repaglinide is considered a safe drug; adverse events are mild to moderate which includes hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas. This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have been noted. We report a case of acute hepatotoxicity in a 78-year-old woman who developed acute hepatotoxicity while taking repaglinide.